Community/Retail

It is halfway to graduation. Have you started studying for the NAPLEX?

Pharmacists may get more patient questions about medication safety, after a video on this subject aired on the World Health Organization’s (WHO) YouTube page.

Draft recommendations are available for comment until November.

During a presentation at the 2017 American Academy of Family Physicians FMX annual meeting, held this year in San Antonio, Texas, Dan Merenstein, MD, presented the evidence surrounding probiotic use.

Clinical pharmacists have proven talents when it comes to managing patients who have diabetes.

The National HIV Surveillance System tracks retention in care for adults diagnosed with HIV, but does not include children in its assessment.

Rivaroxaban with or without aspirin was evaluated for the secondary prevention of cardiovascular outcomes

Last year, 14 out of 100 graduating pharmacy students reported not taking any loans. How?

Your professional viability and professional growth are important. Be proactive, prepared, and stay ahead of the curve.

In October, we celebrate American Pharmacists Month.

Have you ever considered pursuing a PGY-2 pharmacy residency in psychiatry?

A 3-step process to compare pharmacy schools' prerequisites and set an application timeline.

Imagine you are blind. How do you tell one prescription bottle from the next?

It is currently the first and only extended-release, intra-articular injection available for OA.

The study found patients who were prescribed antibiotics for dental procedures tended to be older and more likely to receive clindamycin, an antibiotic that is associated with C diff infection.

FDA officials have approved an 80-mg capsule strength of Neurocrine Biosciences’ valbenazine (Ingrezza) for the treatment of adults with tardive dyskinesia (TD), the company announced in a press release

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

FDA officials have approved the first test for screening Zika virus in blood donations.

The National Community Pharmacists Association (NCPA) shared with Congress eight recommendations for leveraging independent community pharmacists' knowledge and proximity to patients to help address the opioid crisis.

A fixed-dose combination of bictegravir and emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) was non-inferior to boosted protease inhibitor (bPI)-based regimens in virologically suppressed adults with HIV, according to a recently-published phase 3 study.

Oral vitamin D supplementation, in addition to asthma medications, could reduce the risk of asthma attacks requiring hospital attendance by 50%, according to a recently-published study in The Lancet of Respiratory Medicine.

Achieving National HIV/AIDs target goal could prevent an estimated 200,000 deaths over 20 years, according to a study recently published in the Journal of Infectious Diseases.

Vaccination offers protection from harmful diseases, such as hepatitis B, measles and pertussis, and pharmacists can counsel parents.

Social media has become a crucial tool for organizations and businesses to interact with their customers and discuss the services they offer. Many Americans look to social media for recommendations and to build stronger relationships with the brands they use.

Patients who develop chronic kidney disease (CKD) are at risk for a number of comorbidities, including cardiovascular decline.

FDA officials have approved onabotulinumtoxinA (BOTOX Cosmetic, Allergan) for its third indication for the temporary improvement in the appearance of moderate-to-severe forehead lines associated with frontalis muscle activity in adults.

According to an "FDA in Brief" report, officials with the FDA received an adverse event report on August 14, 2017, from a physician concerning a patient who was diagnosed postoperatively with bilateral hemorrhagic occlusive retinal vasculitis (HORV).

People with work-related asthma are particularly vulnerable to pneumococcal pneumonia.